Raf Lambrecht

Raf Lambrecht is the current VP, Head of Regulatory at Nurix. Raf has over 20 years of experience in the Regulatory Affairs field. Raf started their career at Medgenix Diagnostics in 1987 as Manager QA/RA. Raf then moved to Baxter in 1994 as Senior Regulatory Officer. In 1997 they transferred to Bayer Healthcare LLC as Deputy Director Regulatory Affairs. In 2005 they joined FibroGen, Inc. as Executive Director, Regulatory Affairs and remained there until 2020 when they joined Nurix.

Raf Lambrecht has a MBA from Saint Mary's College of California and a Ph.D. in Radiopharmaceuticals from State University of Ghent, Belgium. Raf also has a Masters in Pharmacology from State University of Ghent, Belgium.

Raf Lambrecht reports to Arthur T. Sands, President, CEO & Board Director. Raf Lambrecht works with Buckley Kohlhauff - SVP, IT, Kim Trahan - VP & Head of Program & Portfolio Management, and Robert J. Brown - EVP, Head of Clinical Development.